Related Experiment Video
Updated: Jul 31, 2025
12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
23.0K
Pediatric deep venous thrombosis associated with Staphylococcus aureus osteomyelitis
Linlin Liu1, Lingyun Guo1, Zhuangzhuang Wang1
1Key Laboratory of Major Diseases in Children, Ministry of Education, Department of Infectious Diseases, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Journal of Infection in Developing Countries
|May 9, 2023
Summary
Deep venous thrombosis (DVT) affects over 20% of children with Staphylococcus aureus acute hematogenous osteomyelitis (AHO). Most cases resolved within 3 weeks of anticoagulation without complications.
Area of Science:
- Pediatric Infectious Diseases
- Hematology
- Orthopedic Surgery
Background:
- Deep venous thrombosis (DVT) is a recognized complication of acute hematogenous osteomyelitis (AHO).
- Staphylococcus aureus is a common pathogen in pediatric AHO.
- The clinical presentation and outcomes of concurrent DVT in pediatric AHO require further elucidation.
Purpose of the Study:
- To evaluate the clinical features of children diagnosed with both DVT and AHO caused by Staphylococcus aureus.
- To compare the characteristics of AHO patients with and without DVT.
- To assess the resolution rate and outcomes of DVT in this patient population.
Main Methods:
- Retrospective analysis of medical records over 4 years.
- Inclusion criteria: pediatric patients with AHO and DVT caused by Staphylococcus aureus.
- Comparison of clinical and biochemical data between AHO patients with and without DVT, and analysis of DVT resolution timelines.
Main Results:
- DVT was identified in 22% of pediatric Staphylococcus aureus AHO cases.
- Methicillin-susceptible Staphylococcus aureus (MSSA) was the causative agent in over half of the cases.
- Patients with DVT were older and presented with higher inflammatory markers, positive blood cultures, and longer hospital stays.
Conclusions:
- Over 20% of pediatric Staphylococcus aureus AHO cases are complicated by DVT.
- MSSA is a frequent cause of concurrent DVT and AHO.
- Anticoagulation therapy led to complete DVT resolution in over 50% of cases within 3 weeks, with no reported sequelae.
Related Concept Videos
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
17
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
17
01:30Venous Thrombosis I: Introduction
14
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
14
01:29Venous Thrombosis III: Interprofessional Care
12
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
12
01:30Venous Thrombosis IV: Nursing Management
17
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
17
01:24Hemodialysis II: Procedure and Complications
43
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
43
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
15
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
15